PharmaTher Announces Successful Completion of Pre-IND Meeting with FDA for the Clinical Development of Ketamine in the Treatment of Parkinson’s Disease

02/04/2021 TORONTO, Feb. 04, 2021 (GLOBE NEWSWIRE) — Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary,

Read more

NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100™ (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19

 RLF-100™ therapy associated with a 9-fold increased probability of survival and recovery from respiratory failure in an open-label, prospective study

Read more

Q BioMed, Inc. CEO Discusses Recently Announced International Market Authorizations and Expansion in to South and Central America and Asia for Q BioMed’s Strontium89, its FDA Approved Drug for the Non-Opioid Treatment of Metastatic Cancer in the Bon

AUSTIN, Texas, Sept. 22, 2020 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q

Read more

CytRx Highlights Orphazyme’s Receipt of FDA Acceptance and Priority Review of its New Drug Application for arimoclomol for Niemann-Pick disease Type C

CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company specializing principally in oncology and neurodegenerative diseases, today highlighted that

Read more

OPTEC Introduces Advanced New FDA Approved PPE Products for On-Line Resale & Distributor Network, Including “Breast Cancer Awareness Month 13+” Limited Edition Face Mask

CARLSBAD, CA / ACCESSWIRE / September 16, 2020 / OPTEC International, Inc (OTC PINK:OPTI) OPTEC announced that the company has introduced

Read more